* Phenotype mapping Key
1 => The disorder is placed on the map based on its association with a gene, but the underlying defect is not known
2 => The disorder has been placed on the map by linkage; no mutation has been found
3 => The molecular basis for the disorder is known; a mutation has been found in the gene
4 => A contiguous gene deletion or duplication syndrome, multiple genes are deleted or duplicated causing the phenotype
| Gene Symbol | Chromosomal Location | Gene MIM number | Mapping Method | Phenotype | Phenotype MIM number | Phenotype Mapping Key |
| FGFR2 | 10q26.13 | 176943 | A, Psh, Fd | Crouzon syndrome, 123500 (3) | 123500 | 3 |
| FGFR2 | 10q26.13 | 176943 | A, Psh, Fd | Jackson-Weiss syndrome, 123150 (3) | 123150 | 3 |
| FGFR2 | 10q26.13 | 176943 | A, Psh, Fd | Beare-Stevenson cutis gyrata syndrome, 123790 (3) | 123790 | 3 |
| FGFR2 | 10q26.13 | 176943 | A, Psh, Fd | Pfeiffer syndrome, 101600 (3) | 101600 | 3 |
| FGFR2 | 10q26.13 | 176943 | A, Psh, Fd | Apert syndrome, 101200 (3) | 101200 | 3 |
| FGFR2 | 10q26.13 | 176943 | A, Psh, Fd | Saethre-Chotzen syndrome, 101400 (3) | 101400 | 3 |
| FGFR2 | 10q26.13 | 176943 | A, Psh, Fd | Craniosynostosis, nonspecific (3) | NA | NA |
| FGFR2 | 10q26.13 | 176943 | A, Psh, Fd | Gastric cancer, somatic, 613659 (3) | 613659 | 3 |
| FGFR2 | 10q26.13 | 176943 | A, Psh, Fd | Craniofacial-skeletal-dermatologic dysplasia, 101600 (3) | 101600 | 3 |
| FGFR2 | 10q26.13 | 176943 | A, Psh, Fd | Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3) | 207410 | 3 |
| FGFR2 | 10q26.13 | 176943 | A, Psh, Fd | Scaphocephaly and Axenfeld-Rieger anomaly (3) | NA | NA |
| FGFR2 | 10q26.13 | 176943 | A, Psh, Fd | LADD syndrome, 149730 (3) | 149730 | 3 |
| FGFR2 | 10q26.13 | 176943 | A, Psh, Fd | Scaphocephaly, maxillary retrusion, and mental retardation, 609579 (3) | 609579 | 3 |
| FGFR2 | 10q26.13 | 176943 | A, Psh, Fd | Bent bone dysplasia syndrome, 614592 (3) | 614592 | 3 |